CINECA IRIS Institutional Research Information System

BERRUTI, Alfredo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.023
EU - Europa 6.384
AS - Asia 3.456
SA - Sud America 153
AF - Africa 96
OC - Oceania 89
Continente sconosciuto - Info sul continente non disponibili 10
Totale 19.211
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.797
CN - Cina 1.559
IT - Italia 1.025
DE - Germania 868
IE - Irlanda 747
SE - Svezia 717
SG - Singapore 690
FR - Francia 605
UA - Ucraina 572
FI - Finlandia 456
KR - Corea 389
GB - Regno Unito 320
PL - Polonia 223
AT - Austria 204
VN - Vietnam 184
CA - Canada 182
JP - Giappone 173
IN - India 139
ES - Italia 128
BR - Brasile 92
AU - Australia 83
NL - Olanda 73
DK - Danimarca 71
TR - Turchia 69
BE - Belgio 68
RU - Federazione Russa 61
HK - Hong Kong 51
SN - Senegal 50
ID - Indonesia 46
HU - Ungheria 39
TW - Taiwan 37
CH - Svizzera 36
MX - Messico 36
CZ - Repubblica Ceca 32
GR - Grecia 27
TH - Thailandia 24
PT - Portogallo 23
AR - Argentina 21
EG - Egitto 19
NO - Norvegia 18
IR - Iran 17
CL - Cile 14
MY - Malesia 13
PK - Pakistan 13
PH - Filippine 12
RO - Romania 12
SA - Arabia Saudita 12
CO - Colombia 11
EU - Europa 9
HR - Croazia 9
PE - Perù 9
UZ - Uzbekistan 8
BA - Bosnia-Erzegovina 7
BG - Bulgaria 7
MK - Macedonia 7
DZ - Algeria 6
EC - Ecuador 6
NZ - Nuova Zelanda 6
RS - Serbia 6
ZA - Sudafrica 6
LB - Libano 5
LT - Lituania 5
MU - Mauritius 5
BY - Bielorussia 4
SI - Slovenia 4
IL - Israele 3
KE - Kenya 3
LV - Lettonia 3
MA - Marocco 3
CR - Costa Rica 2
EE - Estonia 2
GT - Guatemala 2
IQ - Iraq 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
MM - Myanmar 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CU - Cuba 1
CY - Cipro 1
ET - Etiopia 1
IM - Isola di Man 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MC - Monaco 1
MT - Malta 1
NG - Nigeria 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 19.211
Salva come PNG Salva come JPEG
Città #
Beijing 1.011
Chandler 1.006
Dublin 698
Houston 673
Ann Arbor 536
Santa Clara 524
Singapore 511
Fairfield 373
Villeurbanne 373
Jacksonville 313
Ashburn 270
Princeton 250
Wilmington 230
Medford 226
Columbus 213
Nyköping 209
Woodbridge 203
Warsaw 202
Vienna 195
Redwood City 185
Dearborn 180
Seattle 152
Torino 137
Cambridge 134
Fremont 133
Boston 118
Dong Ket 112
Pisa 108
Guangzhou 99
Milan 98
Nuremberg 70
Toronto 63
New York 59
Shanghai 58
Munich 51
Brescia 48
Turin 48
Tokyo 46
Boardman 41
Jakarta 41
San Diego 38
Verona 35
Nanjing 34
Norwalk 34
Brussels 32
Los Angeles 30
Falls Church 29
Helsinki 28
Rome 28
Menlo Park 27
Hangzhou 26
London 26
Madrid 26
Seoul 26
Chengdu 24
Lachine 24
Pune 24
Budapest 23
Jinan 23
Moscow 22
Phoenix 22
Brno 21
Düsseldorf 21
Hefei 21
Mountain View 21
Taipei 21
Paris 19
Chicago 18
Kunming 18
Washington 18
Barcelona 17
Istanbul 17
Shenyang 17
São Paulo 17
Hanoi 16
Amsterdam 15
Central 15
Naples 15
Lappeenranta 14
Ottawa 14
Sydney 14
Zhengzhou 14
Rochester 13
Duncan 12
Monash 12
Tappahannock 12
Bethesda 11
Central District 11
Montréal 11
Silver Spring 11
Ankara 10
Athens 10
Detroit 10
Frankfurt am Main 10
Pittsburgh 10
Szekszárd 10
Vancouver 10
Zurich 10
Bengaluru 9
Bogotá 9
Totale 11.132
Salva come PNG Salva come JPEG
Nome #
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. 686
Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain 633
Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy. 565
Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients 552
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 417
Restless Legs Syndrome as a Cause of Sleep Disturbances in Cancer Patients Receiving Chemotherapy 371
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma 370
Management of adjuvant mitotane therapy following resection of adrenal cancer. 330
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. 330
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 294
The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome 287
Quality of Life, Anxiety and Depression in Soft Tissue Sarcomas as Compared to More Common Tumours: An Observational Study 244
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease 243
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 220
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen 181
Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis 174
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 170
Bevacizumab Plus Octreotide and Metronomic Capecitabine in Patients with Metastatic Well-to-Moderately Differentiated Neuroendocrine Tumors. The XELBEVOCT Multicenter Phase II Study 169
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. 161
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 158
Pros-IT CNR: an Italian prostate cancer monitoring project 154
CIRCADIAN RHYTHM OF BONE TURNOVER MARKERS INBREAST CANCER PATIENTS WITH METASTATIC BONE DISEASE ANDIN CONTROL SUBJECTS 152
Enzalutamide in prostate cancer after chemotherapy. 146
Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features. 144
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 143
A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients 139
Adjunctive treatment of adrenocortical carcinoma 135
Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases. 128
Stage IB malignant thymoma in a Lynch syndrome patient with multiple cancers: response to incidental administration of oxaliplatin and 5-fluorouracil 128
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) 127
The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients 127
THE ROLE OF HEMOGLOBIN LEVEL IN PREDICTING THE RESPONSE TO FIRST-LINE CHEMOTHERAPY IN ADVANCED COLORECTAL CANCER (ACC) PATIENTS 123
Efficacia del reintervento chirurgico in pazienti con carcinoma del cortico-surrene recidivo 120
La recidiva di carcinoma del cortico-surrene:trattamento chirurgico o chemioterapico? 117
Confronto tra due metodi per la misura della concentrazione della cromogranina A circolante in pazienti con iperplasia prostatica benigna e adenocarcinoma prostatico 116
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer 113
Adjuvant mitotane treatment: a prospective experience at the San luigi Hospital, University of Turin, Italy, USA, 2008 111
Chromogranine A serum levels in patients affected by prostate cancer and benign prostate hypertrophy: comparison between two different commercial kits 111
Efficacy of repeat surgery in patients with recurrent adrenocortical cancer (ACC) 109
An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer 109
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma 106
A randomized comparison of high dose epirubicin versus high dose epirubicin plus lonidamine in advanced breast cancer patients. First results from a cooperative group study 105
Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma. 104
Case-control study of the impact of adjuvant hormone therapy in prostate cancer patients on quality of life, anxiety and depression and self body image perception 104
A prospective study on adjuvant mitotane 103
Circadian rhythm of breakthrough cancer pain. 101
Melatonin and human cancer. 97
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial. 97
The San Luigi hospital experience with adjuvant mitotane treatment in patients with adrenocortical cancer following radical resection 97
Cytotoxic effect of trabectedin in human adrenocortical carcinoma cell lines and primary cells 97
Comparison between two commercially available chromogranin A assays in detecting neuroendocrine differentiation in prostate cancer and benign prostate hyperplasia 95
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up† 95
Distúrbio Pós-Traumático de Stress, qualidade do sono, ansiedade, depressão e qualidade de vida em pacientes oncológicos em tratamento quimioterápico 94
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 94
Acute myeloblastic leukemia associated with mediastinal nonseminomatous germ cell tumors. Report on two cases. 93
Effects of Serum Testosterone Levels After 6 Months of Androgen Deprivation Therapy on the Outcome of Patients With Prostate Cancer. 93
A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy. 2012 Apr 1;3(4):819-824. Epub 2012 Jan 16. PubMed Central PMCID: PMC3362404. 92
The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients 91
Does nephrectomy during adrenalectomy for adrenal cancer improve oncological results? 91
Adjuvant mitotane in adrenocortical carcinoma - Reply 90
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer 90
PROGNOSTIC ROLE OF SERUM TESTOSTERONE LEVELS IN PROSTATE CANCER PATIENTS DURING ANDROGEN-DEPRIVATION THERAPY 89
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 89
Biochemical picture of bone metabolism in breast cancer patients with bone metastases. 88
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma 85
Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930. 84
Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension. 84
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients. 83
Changes in body composition after androgen deprivation therapy (ADT) in prostate cancer patients. Relationship with disease outcome 82
Potential clinical value of circulating chromogranin A in patients with prostate carcinoma. 82
A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbA phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbine 81
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. 81
Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer. 81
The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load. 81
Development and validation of a patient-physician relationship index in the advanced cancer setting 81
Risk of depressive events in long-term surviving patients affected by hormone-related cancer according to time after diagnosis 80
Cytotoxic chemotherapy for adrenocortical carcinoma. 79
Background to and management of treatment-related bone loss in prostate cancer. 78
Emerging drugs for adrenocortical carcinoma 77
Circadian rhythm of bone turnover markers in breast cancer patients with bone metastases and in control subjects 77
Influence of neoadjuvant chemotherapy on serum tumor markers CA 15-3, MCA, CEA, TPS and TPA in breast cancer patients with operable disease. 76
Efficacia del reintervento chirurgico in pazienti con carcinoma del cortico-surrene recidivo 76
Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy 76
Advances in pancreatic neuroendocrine tumor treatment. 76
THE ONSET OF SKELETAL COMPLICATIONS IN HORMONEREFRACTORY PROSTATE CANCER PATIENTS IS NOT INFLUENCEDBY THE DURATION OF ANDROGEN DEPRIVATION THERAPY 76
PALLIATIVE CARE PATIENTS HAD A CIRCADIAN RHYTHMICITY IN THEIR BREAKTHROUGH PAIN (BTP) EPISODES 75
Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse. 74
The role of hemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer (ACC) 73
Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review. 73
Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas 73
Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone. 72
Osteoblastic flare assessed by serum alkaline phosphatase activity is an index of short duration of response in prostate cancer patients with bone metastases submitted to systemic therapy.Gruppo Onco Urologico Piemontese (G.O.U.P). 71
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly 71
Pitfalls in the diagnosis of adrenocortical tumors: A lesson from 300 consultation cases 71
Expression analysis of genes involved in DNA repair or synthesis in mixed neuroendocrine/nonneuroendocrine carcinomas 70
Durable complete remission after weekly docetaxel administration in a patient with mediastinal non-seminomatous germ-cell tumor refractory to cisplatin-based chemotherapy 70
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 70
Somatostatin receptors: from basic science to clinical approach. Unlabeled somatostatin analogues-1: Prostate cancer 69
Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 69
Metronomic therapy concepts in the management of adrenocortical carcinoma. 68
Totale 14.147
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.034
article - articoli 0
book - libri 0
conference - conferenze 7.399
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.433
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.226 0 0 0 0 0 0 336 161 252 204 170 103
2020/20211.980 172 111 176 91 161 94 249 126 219 186 112 283
2021/20222.569 100 91 110 402 167 126 220 135 75 120 452 571
2022/20233.220 397 297 85 296 255 802 257 210 299 63 166 93
2023/20241.591 203 243 104 95 72 183 45 80 27 125 202 212
2024/20251.982 111 258 146 346 878 235 8 0 0 0 0 0
Totale 19.891